FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

386892006: Grepafloxacin (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461070011 Grepafloxacin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481006013 Grepafloxacin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Grepafloxacin (substance) Is a Quinolone antibacterial false Inferred relationship Some
Grepafloxacin (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some
Grepafloxacin (substance) Is a Fluoroquinolone (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing grepafloxacin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Grepafloxacin (substance) Inferred relationship Some 1
Product containing precisely grepafloxacin 200 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Grepafloxacin (substance) Inferred relationship Some
Grepafloxacin 400 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Grepafloxacin (substance) Inferred relationship Some
Product containing precisely grepafloxacin 600 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Grepafloxacin (substance) Inferred relationship Some
Grepafloxacin hydrochloride Is a False Grepafloxacin (substance) Inferred relationship Some
Product containing precisely grepafloxacin 200 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Grepafloxacin (substance) Inferred relationship Some 1
Product containing precisely grepafloxacin 200 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Grepafloxacin (substance) Inferred relationship Some 1
Grepafloxacin 400 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Grepafloxacin (substance) Inferred relationship Some 1
Grepafloxacin 400 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Grepafloxacin (substance) Inferred relationship Some 1
Product containing precisely grepafloxacin 600 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Grepafloxacin (substance) Inferred relationship Some 1
Product containing precisely grepafloxacin 600 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Grepafloxacin (substance) Inferred relationship Some 1
Grepafloxacin 400 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Grepafloxacin (substance) Inferred relationship Some 1
Product containing precisely grepafloxacin 200 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Grepafloxacin (substance) Inferred relationship Some 1
Product containing precisely grepafloxacin 600 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Grepafloxacin (substance) Inferred relationship Some 1
Grepafloxacin-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Grepafloxacin (substance) Inferred relationship Some 1
Grepafloxacin hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Grepafloxacin (substance) Inferred relationship Some
Product containing only grepafloxacin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Grepafloxacin (substance) Inferred relationship Some 1
Grepafloxacin only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Grepafloxacin (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start